Gilead says late-stage remdesivir trial shows improvement in some patients

Posted by on June 1, 2020 9:42 am
Categories: US National Stories

Gilead Sciences shares fell after results from a phase 3 trial showed its antiviral drug remdesivir helped some patients with moderate Covid-19.

Leave a Reply

Your email address will not be published. Required fields are marked *